Michael Blind

1.6k total citations
21 papers, 1.3k citations indexed

About

Michael Blind is a scholar working on Molecular Biology, Genetics and Electrical and Electronic Engineering. According to data from OpenAlex, Michael Blind has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Electrical and Electronic Engineering. Recurrent topics in Michael Blind's work include Advanced biosensing and bioanalysis techniques (17 papers), RNA and protein synthesis mechanisms (12 papers) and RNA Interference and Gene Delivery (7 papers). Michael Blind is often cited by papers focused on Advanced biosensing and bioanalysis techniques (17 papers), RNA and protein synthesis mechanisms (12 papers) and RNA Interference and Gene Delivery (7 papers). Michael Blind collaborates with scholars based in Germany, United Kingdom and Sweden. Michael Blind's co-authors include Michael Famulok, Michael Blank, Günter Mayer, Waldemar Kolanus, Petra Burgstaller, Andreas Jenne, Catherine Jackson, Thomas Knorr, Wolfgang Nagel and Thomas Böhm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Accounts of Chemical Research.

In The Last Decade

Michael Blind

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Blind Germany 15 1.2k 342 91 89 70 21 1.3k
Masayasu Kuwahara Japan 28 1.9k 1.5× 328 1.0× 106 1.2× 188 2.1× 41 0.6× 87 2.0k
Meghan B. O’Donoghue United States 10 1.2k 0.9× 516 1.5× 83 0.9× 72 0.8× 62 0.9× 13 1.4k
Kalim U. Mir United Kingdom 16 1.4k 1.1× 496 1.5× 147 1.6× 95 1.1× 53 0.8× 30 1.8k
Scott E. Osborne United States 11 937 0.8× 204 0.6× 44 0.5× 58 0.7× 56 0.8× 15 1.0k
Román F. Macaya United States 7 1.5k 1.2× 197 0.6× 100 1.1× 115 1.3× 16 0.2× 9 1.5k
Robert A. Langan United States 7 790 0.6× 154 0.5× 48 0.5× 72 0.8× 107 1.5× 8 974
Soma Dhakal United States 22 1.6k 1.3× 383 1.1× 144 1.6× 212 2.4× 32 0.5× 41 1.7k
Theo T. Nikiforov United States 17 557 0.5× 349 1.0× 127 1.4× 44 0.5× 36 0.5× 33 977
Eric Dausse France 18 791 0.6× 178 0.5× 44 0.5× 78 0.9× 33 0.5× 45 900
Taiichi Sakamoto Japan 16 813 0.7× 114 0.3× 43 0.5× 76 0.9× 74 1.1× 57 914

Countries citing papers authored by Michael Blind

Since Specialization
Citations

This map shows the geographic impact of Michael Blind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Blind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Blind more than expected).

Fields of papers citing papers by Michael Blind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Blind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Blind. The network helps show where Michael Blind may publish in the future.

Co-authorship network of co-authors of Michael Blind

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Blind. A scholar is included among the top collaborators of Michael Blind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Blind. Michael Blind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blind, Michael & Michael Blank. (2015). Aptamer Selection Technology and Recent Advances. Molecular Therapy — Nucleic Acids. 4. e223–e223. 256 indexed citations
2.
Kelly, T., et al.. (2015). Selective Aptamer‐Based Control of Intraneuronal Signaling. Angewandte Chemie. 127(18). 5459–5463. 2 indexed citations
3.
Blank, Michael, et al.. (2015). Positive Modulation of the Glycine Receptor by Means of Glycine Receptor–Binding Aptamers. SLAS DISCOVERY. 20(9). 1112–1123. 9 indexed citations
4.
Kelly, T., et al.. (2015). Selective Aptamer‐Based Control of Intraneuronal Signaling. Angewandte Chemie International Edition. 54(18). 5369–5373. 8 indexed citations
5.
Blind, Michael, et al.. (2014). An Aptamer to the MAP Kinase Insert Region. ACS Chemical Biology. 10(1). 320–327. 5 indexed citations
6.
Blank, Michael, et al.. (2010). In vitro selection of RNA aptamers that inhibit the activity of type A botulinum neurotoxin. Biochemical and Biophysical Research Communications. 396(4). 854–860. 36 indexed citations
7.
Mayer, Günter, Marcus Klotzsche, Michael Blind, et al.. (2009). An RNA Aptamer that Induces Transcription. Chemistry & Biology. 16(2). 173–180. 47 indexed citations
8.
Mayer, Günter, et al.. (2009). From selection to caged aptamers: Identification of light-dependent ssDNA aptamers targeting cytohesin. Bioorganic & Medicinal Chemistry Letters. 19(23). 6561–6564. 16 indexed citations
9.
Mayer, Günter, et al.. (2009). A RNA‐Based Approach towards Small‐Molecule Inhibitors. ChemBioChem. 10(12). 1993–1996. 9 indexed citations
10.
Schmoldt, Hans‐Ulrich, et al.. (2009). Microbodies™. Methods in molecular biology. 535. 361–372. 2 indexed citations
11.
Gronewold, Thomas M. A., Saleta Sierra, Michael Blind, et al.. (2009). Kinetic Binding Analysis of Aptamers Targeting HIV-1 Proteins by a Combination of a Microbalance Array and Mass Spectrometry (MAMS). Journal of Proteome Research. 8(7). 3568–3577. 22 indexed citations
12.
Mayer, Günter, Christian D. Huber, Lars Neumann, et al.. (2008). An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. RNA. 14(3). 524–534. 45 indexed citations
13.
Blind, Michael, et al.. (2006). Using Aptamers as Capture Reagents in Bead-Based Assay Systems for Diagnostics and Hit Identification. SLAS DISCOVERY. 11(7). 773–781. 34 indexed citations
14.
Blank, Michael & Michael Blind. (2005). Aptamers as tools for target validation. Current Opinion in Chemical Biology. 9(4). 336–342. 101 indexed citations
15.
Burgstaller, Petra, Andreas Jenne, & Michael Blind. (2002). Aptamers and aptazymes: accelerating small molecule drug discovery.. PubMed. 5(5). 690–700. 41 indexed citations
16.
Famulok, Michael, Michael Blind, & Günter Mayer. (2001). Intramers as promising new tools in functional proteomics. Chemistry & Biology. 8(10). 931–939. 75 indexed citations
17.
Mayer, Günter, et al.. (2001). Aptamers that bind to the antibiotic moenomycin A. Bioorganic & Medicinal Chemistry. 9(10). 2557–2563. 42 indexed citations
18.
Mayer, Günter, Michael Blind, Wolfgang Nagel, et al.. (2001). Controlling small guanine–nucleotide-exchange factor function through cytoplasmic RNA intramers. Proceedings of the National Academy of Sciences. 98(9). 4961–4965. 84 indexed citations
19.
Famulok, Michael, Günter Mayer, & Michael Blind. (2000). Nucleic Acid AptamersFrom Selection in Vitro to Applications in Vivo. Accounts of Chemical Research. 33(9). 591–599. 373 indexed citations
20.
Blind, Michael, Waldemar Kolanus, & Michael Famulok. (1999). Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. Proceedings of the National Academy of Sciences. 96(7). 3606–3610. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayasu Kuwahara Breakdown of academic impact, for papers by Meghan B. O’Donoghue Breakdown of academic impact, for papers by Kalim U. Mir Breakdown of academic impact, for papers by Scott E. Osborne Breakdown of academic impact, for papers by Román F. Macaya Breakdown of academic impact, for papers by Robert A. Langan Breakdown of academic impact, for papers by Soma Dhakal Breakdown of academic impact, for papers by Theo T. Nikiforov Breakdown of academic impact, for papers by Eric Dausse Breakdown of academic impact, for papers by Taiichi Sakamoto
Rankless by CCL
2026